| Global X S&P 500 Covered Call ETF (UYLD) |
Financials |
$15 |
Global X Updated Est Distribution Announcement - August 2025
|
28 Aug 2025 5:17PM |
$10.800 |
$10.830 |
risen by
0.28%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,608 |
Appendix 4E
|
28 Aug 2025 5:15PM |
$1.290 |
$1.635 |
risen by
26.74%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited released its Appendix 4E, which is a preliminary final report for the year ended 31 December 2023.
- The company is engaged in the development of RNA therapeutics, focusing on the treatment of inherited retinal diseases and other genetic disorders.
- There were no dividends paid or recommended during the reporting period.
- The net loss after tax attributable to members for the year was $28,009,000, compared to a net loss after tax of $22,601,000 in the previous year.
- Comprehensive loss for the year attributable to members was $27,977,000, compared to $22,601,000 in the previous year.
- Basic and diluted loss per share were both 2.32 cents, compared to 2.10 cents in the previous year.
- The report provides detailed commentary on the results, including progress of clinical trials, pipeline developments, and financial highlights.
- PYC Therapeutics Limited continues to invest in the development of its therapeutic candidates and anticipates further clinical milestones in the coming periods.
- The Appendix 4E includes the annual financial results, commentary on operations, and outlines significant activities undertaken by the company during the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brazilian Critical Minerals Limited (BCM) ORDINARY FULLY PAID |
Materials |
$104 |
Loan Conversion and Raising
|
28 Aug 2025 5:15PM |
$0.023 |
$0.053 |
risen by
130.43%
|
|
BCM - Price-sensitive ASX Announcement
Full Release
Key Points
- BCM announced loan conversion and capital raising on 6 June 2024.
- $1.05 million of loans converted into equity at $0.07 per share.
- 15 million shares issued to directors and major shareholders for loan conversion.
- $3.25 million raised through placement of 46.43 million shares at $0.07 per share.
- Placement shares issued to sophisticated and professional investors under Listing Rule 7.1.
- Funds to be used for exploration, development, and working capital for BCM's Brazilian mineral projects.
- Board thanked shareholders and emphasized strategic importance of the funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ampol Limited (ALD) ORDINARY FULLY PAID |
Energy |
$7,907 |
Notification regarding unquoted securities - ALD
|
28 Aug 2025 5:14PM |
$29.410 |
$33.180 |
risen by
12.82%
|
|
| Health and Plant Protein Group Limited (HPP) ORDINARY FULLY PAID |
Consumer Staple |
- |
Business update - HPP and REES
|
28 Aug 2025 5:14PM |
$0.042 |
$0.042 |
fallen by
0%
|
|
| Harris Technology Group Limited (HT8) ORDINARY FULLY PAID |
Consumer Discretionary |
$8 |
FY25 Results Commentary
|
28 Aug 2025 5:11PM |
$0.012 |
$0.021 |
risen by
75%
|
|
| Harris Technology Group Limited (HT8) ORDINARY FULLY PAID |
Consumer Discretionary |
$8 |
Preliminary Final Report
|
28 Aug 2025 5:11PM |
$0.012 |
$0.021 |
risen by
75%
|
|
HT8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the year ended 30 June 2023 was $27.65 million, down from $51.12 million in 2022.
- Net loss after tax was $2.91 million, compared to a loss of $2.04 million in the previous year.
- Decline in revenue attributed to post-pandemic e-commerce competition and challenging trading conditions.
- Cost management and operational efficiency initiatives were a focus during the year.
- No dividends were declared for the reporting period.
- HT8 undertook product range expansion and strengthened supplier relationships to adapt to market conditions.
- The company is pursuing strategies to return to profitability through improved sales channels, diversification, and customer service enhancements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chalice Mining Limited (CHN) ORDINARY FULLY PAID |
Materials |
$445 |
Notification regarding unquoted securities - CHN
|
28 Aug 2025 5:11PM |
$1.745 |
$1.143 |
fallen by
34.53%
|
|
| Rumble Resources Limited (RTR) ORDINARY FULLY PAID |
Materials |
$60 |
Restricted Securities to be Released from Voluntary Escrow
|
28 Aug 2025 5:08PM |
$0.029 |
$0.045 |
risen by
55.17%
|
|
| My Foodie Box Limited (MBX) ORDINARY FULLY PAID |
Consumer Staple |
- |
Change of Registered Office and Place of Business
|
28 Aug 2025 5:08PM |
$0.004 |
$0.004 |
fallen by
0%
|
|
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$646 |
Change in substantial holding
|
28 Aug 2025 5:07PM |
$1.355 |
$0.935 |
fallen by
31%
|
|
| Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$330 |
Notification of cessation of securities - PBH
|
28 Aug 2025 5:06PM |
$1.260 |
$0.950 |
fallen by
24.60%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$14 |
Appendix 4G & Corporate Governance Statement
|
28 Aug 2025 5:06PM |
$0.640 |
$0.110 |
fallen by
82.81%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$14 |
Appendix 4E & Annual Report to 30 June 2025
|
28 Aug 2025 5:05PM |
$0.640 |
$0.110 |
fallen by
82.81%
|
|
AGN - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase 1 clinical trial for ARG-007, demonstrating safety and tolerability in healthy participants
- Initiation of Phase 2a clinical trial in acute ischaemic stroke patients
- Advancement of preclinical studies for traumatic brain injury and hypoxic ischaemic encephalopathy
- Ongoing research and development investment leading to reported loss for the financial year
- Detailed cash flow and funding disclosures, including capital raisings to support clinical progression
- Focus on expanding ARG-007’s indications and progressing clinical and regulatory milestones
- Emphasis on corporate governance, risk management, and strategic planning for future growth
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nufarm Limited (NUF) ORDINARY FULLY PAID |
Materials |
$1,012 |
Change in substantial holding
|
28 Aug 2025 5:03PM |
$2.440 |
$2.635 |
risen by
7.99%
|
|
| West Wits Mining Limited (WWI) ORDINARY FULLY PAID |
Materials |
$182 |
Change of Director's Interest Notices
|
28 Aug 2025 5:01PM |
$0.034 |
$0.418 |
risen by
1,127.94%
|
|
| Mad Paws Holdings Limited (MPA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
FY2025 Preliminary Full Year Results
|
28 Aug 2025 4:59PM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
MPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Mad Paws Holdings Limited delivered strong FY2025 preliminary full year results with substantial growth across business segments.
- Marketplace and e-commerce divisions showed significant increases in bookings and gross merchandise value.
- Strategic investments in technology and marketing contributed to growth in active users and customer acquisition.
- The Waggly Club subscription service experienced robust adoption and retention rates.
- Financial highlights included revenue growth, improved EBITDA margins, and positive cash flow management.
- Expansion of service offerings and new brand partnerships enhanced overall customer value proposition.
- Management underscored a commitment to innovation, superior customer experience, and sustainable long-term growth.
- Forward guidance indicates continued investments in technology, product development, and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nick Scali Limited (NCK) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,352 |
Becoming a substantial holder
|
28 Aug 2025 4:58PM |
$23.880 |
$15.810 |
fallen by
33.79%
|
|
| Dominion Income Trust 1 (DN1) ORDINARY UNITS FULLY PAID |
Financials |
$343 |
Listing Rule 4.8
|
28 Aug 2025 4:58PM |
$102.000 |
$99.500 |
fallen by
2.45%
|
|
| Count Limited (CUP) ORDINARY FULLY PAID |
Industrials |
$220 |
Date of 2025 Annual General Meeting
|
28 Aug 2025 4:57PM |
$0.980 |
$1.035 |
risen by
5.61%
|
|
| Mad Paws Holdings Limited (MPA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Preliminary Final Report
|
28 Aug 2025 4:56PM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
MPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Mad Paws Holdings Limited reported a 59% increase in revenue for FY23, driven by growth in both the pet services marketplace and e-commerce segments.
- The company achieved improvements in gross margins and reduced operating cash outflows compared to the previous year.
- Net loss after tax for the year was $6.0 million, an improvement from the prior year’s $7.2 million loss.
- Key growth was fueled by the expansion of Waggly Club subscriptions and Mad Paws Food, strengthening recurring revenue streams.
- Operational highlights include the integration of business units, investment in technology, and enhanced marketing strategies to boost user engagement.
- The company’s cash position at year-end was $5.2 million, with a focus on sustainable investment and cost management.
- Risks addressed include market competition, consumer demand variability, and economic conditions impacting discretionary spending.
- Outlook for FY24 involves further expanding services, optimizing operational efficiencies, and striving for profitability.
- The report includes directors’ declarations, compliance statements, and detailed financial notes as required by ASX and accounting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Johns Lyng Group Limited (JLG) ORDINARY FULLY PAID |
Industrials |
- |
Becoming a substantial holder
|
28 Aug 2025 4:55PM |
$3.910 |
$3.990 |
risen by
2.05%
|
|
| Simble Solutions Limited (SIS) ORDINARY FULLY PAID |
Information Technology |
$13 |
Appendix 4D and 1H25 Financial Report
|
28 Aug 2025 4:55PM |
$0.004 |
$0.006 |
risen by
50%
|
|
SIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Simble Solutions Limited released its Appendix 4D and Half-Year Financial Report as of 30 June 2023.
- The company specializes in SaaS-based energy management and data analytics solutions through its SimbleSense platform.
- Revenue for the half-year decreased due to the end of sales through a key channel partner.
- Operating expenses remain significant, with ongoing investment in research and development for product improvement.
- The company recorded a net loss for the half-year, reflecting the challenges in the current market environment.
- Simble is actively pursuing new revenue streams and focusing on cost management to improve financial stability.
- Management is confident in being able to secure further funding to support continued operations and growth.
- The report includes mandatory disclosures, compliance statements, and a review of corporate governance and risk management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bisalloy Steel Group Limited (BIS) ORDINARY FULLY PAID |
Materials |
$208 |
FY25 Full Year Results - ASX Release
|
28 Aug 2025 4:54PM |
$4.420 |
$4.320 |
fallen by
2.26%
|
|
BIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Bisalloy Steel Group Limited announced its FY25 Full Year Results on the ASX.
- The report presents detailed financial performance including revenue, profit, and margin analysis.
- Market conditions, cost pressures, and operational challenges are discussed as factors impacting results.
- The company outlines performance and developments in both domestic and international markets.
- Strategic initiatives and actions undertaken during the year are summarized.
- Future outlook, expectations, and potential business risks are provided.
- Capital management, dividend policy, and shareholder returns are addressed.
- The announcement emphasizes ongoing efforts to adapt to market changes and drive growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bisalloy Steel Group Limited (BIS) ORDINARY FULLY PAID |
Materials |
$208 |
Dividend/Distribution - BIS
|
28 Aug 2025 4:53PM |
$4.420 |
$4.320 |
fallen by
2.26%
|
|